Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Works in Infectious disease · Psychiatry · Respiratory
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. is a clinical trial sponsor. It has 1 active clinical trial with 1,000 planned participants, in Infectious disease, Psychiatry and Respiratory. Since 2021 it has completed 2 trials and stopped 3 early.
Trial track record · since 2021
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Marubeni Pharmaceuticals (Suzhou) Co., Ltd
Marubeni Pharmaceuticals (Suzhou) Co., Ltd is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 1,000 planned participants, in Infectious disease, Psychiatry, Respiratory. Since 2021 it has completed 2 trials and stopped 3 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Marubeni Pharmaceuticals (Suzhou) Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-08-07.
Approve Suite is not affiliated with Marubeni Pharmaceuticals (Suzhou) Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.